Quick Takeaways
- Deep Track Capital, LP filed SCHEDULE 13G for Immunic, Inc. Common Stock, $0.0001 par value (IMUX).
- Disclosed ownership: 8.7%.
- Date of event: 17 Feb 2026.
Deep Track Capital, LP - 17 Feb 2026 SCHEDULE 13G Report for Immunic, Inc. Common Stock, $0.0001 par value (IMUX)
- Filing Manager
- Deep Track Capital, LP
- Reporting Manager
- Deep Track Capital, LP
- Symbol
- IMUX
- Shares outstanding
- 131,806,674 shares
- Disclosed Ownership
- 11,454,000 shares
- Ownership
- 8.7%
- Form type
- SCHEDULE 13G
- Filing time
- 04 Mar 2026, 16:15:11 UTC
- Date of event
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Deep Track Capital, LP disclosed 8.7% ownership in Immunic, Inc. Common Stock, $0.0001 par value (IMUX) on 17 Feb 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 04 Mar 2026, 16:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 8.7% | 11,454,000 | 0 | 11,454,000 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Adviser | |
| Deep Track Biotechnology Master Fund, Ltd. | 6.8% | 8,953,630 | 0 | 8,953,630 | /s/ David Kroin | David Kroin, Director | |
| David Kroin | 8.7% | 11,454,000 | 0 | 11,454,000 | /s/ David Kroin | David Kroin | |
| Deep Track Special Opportunities Fund, LP. | 1.9% | 2,500,370 | 0 | 2,500,370 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Adviser of Deep Track Special Opportunities Fund, LP |